Non-invasive quantification of the beta cell mass by SPECT with 111In-labelled exendin

Development and Evaluation of 18F-TTCO-Cys40-Exendin-4: A PET Probe for Imaging Transplanted Islets

(2013) Z. Wu et al.   JOURNAL OF NUCLEAR MEDICINE

Vesicular monoamine transporter, type 2 (vmat2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas

(2013) Matthew Freeby et al.   Islets

Radiolabelled GLP-1 analogues forin vivotargeting of insulinomas

(2012) Maarten Brom et al.   Contrast Media & Molecular Imaging

Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients

(2012) Ken T. Coppieters et al.   JOURNAL OF EXPERIMENTAL MEDICINE

In Vivo Imaging of Endogenous Pancreatic  -Cell Mass in Healthy and Type 1 Diabetic Subjects Using 18F-Fluoropropyl-Dihydrotetrabenazine and PET

(2012) M. D. Normandin et al.   JOURNAL OF NUCLEAR MEDICINE

In Vivo Imaging of Transplanted Islets with64Cu-DO3A-VS-Cys40-Exendin-4 by Targeting GLP-1 Receptor

(2011) Zhanhong Wu et al.   BIOCONJUGATE CHEMISTRY

Synthesis and evaluation of [18F]exendin (9–39) as a potential biomarker to measure pancreatic β-cell mass

(2011) Yi Wang et al.   NUCLEAR MEDICINE AND BIOLOGY

Accurate measurement of pancreatic islet  -cell mass using a second-generation fluorescent exendin-4 analog

(2011) T. Reiner et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers

(2011) Saskia E. Rademakers et al.   CELLULAR ONCOLOGY

Development of Radiotracers for the Determination of the Beta-Cell Mass In Vivo

(2010) Maarten Brom et al.   CURRENT PHARMACEUTICAL DESIGN

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET

(2010) Maarten Brom et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model

(2010) S. Heskamp et al.   JOURNAL OF NUCLEAR MEDICINE

Exendin-4-Based Radiopharmaceuticals for Glucagonlike Peptide-1 Receptor PET/CT and SPECT/CT

(2010) D. Wild et al.   JOURNAL OF NUCLEAR MEDICINE

C-Peptide Levels and Insulin Independence Following Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus

(2009) Carlos E. B. Couri   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

11C-Dihydrotetrabenazine PET of the Pancreas in Subjects with Long-Standing Type 1 Diabetes and in Healthy Controls

(2009) R. Goland et al.   JOURNAL OF NUCLEAR MEDICINE

VMAT2 quantitation by PET as a biomarker for β-cell mass in health and disease

(2008) M. Freeby et al.   DIABETES OBESITY & METABOLISM

Pancreatic β-cell mass in European subjects with type 2 diabetes

(2008) J. Rahier et al.   DIABETES OBESITY & METABOLISM

Initiation and execution of lipotoxic ER stress in pancreatic  -cells

(2008) D. A. Cunha et al.   JOURNAL OF CELL SCIENCE

Expression of the GLP-1 Receptor in Mouse, Rat, and Human Pancreas

(2008) Ditte Tornehave et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Extent of Beta Cell Destruction Is Important but Insufficient to Predict the Onset of Type 1 Diabetes Mellitus

(2008) David J. Klinke   PLoS One